Page last updated: 2024-09-05

sorafenib and su 5614

sorafenib has been researched along with su 5614 in 1 studies

Compound Research Comparison

Studies (sorafenib)	Trials (sorafenib)	Recent Studies (post-2010) (sorafenib)	Studies (su 5614)	Trials (su 5614)	Recent Studies (post-2010) (su 5614)
6,520	730	5,251	26	0	3

Protein Interaction Comparison

Protein	Taxonomy	sorafenib (IC50)	su 5614 (IC50)
Proto-oncogene tyrosine-protein kinase receptor Ret	Homo sapiens (human)		1

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aberg, E; Duyster, J; Engh, RA; Peschel, C; Sänger, J; von Bubnoff, N	1

Other Studies

1 other study(ies) available for sorafenib and su 5614

Article	Year
FMS-like tyrosine kinase 3-internal tandem duplication tyrosine kinase inhibitors display a nonoverlapping profile of resistance mutations in vitro. Cancer research, 2009, Apr-01, Volume: 69, Issue:7 Topics: Animals; Benzenesulfonates; Cell Line; Drug Resistance; fms-Like Tyrosine Kinase 3; Indoles; Mice; Models, Molecular; Mutagenesis, Site-Directed; Mutation; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Protein Structure, Tertiary; Pyridines; Receptors, Platelet-Derived Growth Factor; Sorafenib; Staurosporine; Tandem Repeat Sequences	2009

Article

Year

FMS-like tyrosine kinase 3-internal tandem duplication tyrosine kinase inhibitors display a nonoverlapping profile of resistance mutations in vitro.

Cancer research, 2009, Apr-01, Volume: 69, Issue:7

Topics: Animals; Benzenesulfonates; Cell Line; Drug Resistance; fms-Like Tyrosine Kinase 3; Indoles; Mice; Models, Molecular; Mutagenesis, Site-Directed; Mutation; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Protein Structure, Tertiary; Pyridines; Receptors, Platelet-Derived Growth Factor; Sorafenib; Staurosporine; Tandem Repeat Sequences

2009